U.S. Physical Therapy, Inc. (USPH) स्टॉक विश्लेषण

कंपनी का अवलोकन

U.S. Physical Therapy, Inc. operates and manages a network of outpatient physical therapy clinics through two primary segments: Physical Therapy Operations and Industrial Injury Prevention Services. The company specializes in delivering pre- and post-operative care and treatment specifically for orthopedic conditions, serving patients within the broader healthcare ecosystem. This entity functions within the Healthcare sector, specifically categorized under the Medical Care Facilities industry, which implies a focus on patient rehabilitation and injury recovery services rather than pharmaceuticals or hospital acute care. The company demonstrates a significant operational scale with a market capitalization of $1.17B, annual revenue reaching $773.34M, and an employee base of 4653 individuals. These valuation and revenue figures indicate that the company holds a substantial position in the outpatient therapy landscape, reflecting a large-scale operation capable of managing extensive clinical networks and industrial safety programs.

वित्तीय स्वास्थ्य

The financial performance for the trailing twelve months shows a revenue of $773.34M, a net income of $21.57M, and an EBITDA of $103.09M. The considerable gap between the revenue of $773.34M and the net income of $21.57M reveals a cost structure with substantial expenses relative to total sales, resulting in a profit margin of only 5.1%. Free cash flow stands at $73.92M, which indicates that the company generates sufficient cash from operations to cover capital expenditures and potentially fund internal growth initiatives or debt reduction. However, the balance sheet presents a leveraged profile where total debt of $315.16M exceeds the cash on hand of $36.31M, a situation further emphasized by a debt-to-equity ratio of 40.92. Liquidity management is tight, as evidenced by a current ratio of 1.01, which suggests that the company's current assets are only slightly greater than its current liabilities, requiring careful working capital management. Return on equity is 7.6% while return on assets is 4.3%, metrics that reveal management effectiveness in generating returns relative to shareholder equity and total asset deployment, though the ROA indicates capital efficiency is moderate given the high leverage.

मूल्यांकन आकलन

Valuation metrics for U.S. Physical Therapy, Inc. show a trailing P/E ratio of 54.04 and a forward P/E of 23.17, implying that the market expects a significant reduction in the P/E multiple or a substantial increase in earnings growth to justify the current valuation over time. The price-to-book ratio is 2.44, indicating that the market values the company at a premium over its net book value, likely due to intangible assets or growth prospects not fully captured on the balance sheet. Alternative valuation measures include a price-to-sales ratio of 1.51 and an EV/EBITDA of 16.81, which suggest that investors are willing to pay more than one dollar of sales for every dollar of revenue generated. The stock has traded between a 52-week high of $93.50 and a 52-week low of $64.55, meaning the current price sits within this historical range but requires calculation to determine the exact percentage distance from the highs. The beta value is 1.35, which signifies that the stock price volatility is higher than the broader market, moving 35% more than the market average in response to market fluctuations.

Growth & Income

Revenue growth for the year-over-year period is 12.5%, while earnings growth for the year-over-year period is listed as N/A. The absence of reported earnings growth data makes a direct comparison between revenue expansion and earnings acceleration impossible, but the 12.5% revenue increase highlights a focus on top-line expansion over immediate profitability scaling. The company offers a dividend yield of 2.4%, yet the payout ratio is 126.8%, indicating that dividends are being paid from a portion of retained earnings or debt rather than current net income. A payout ratio exceeding 100% suggests that the current dividend is not fully supported by earnings generated in the trailing twelve months, which raises questions regarding the sustainability of the dividend payment without a change in earnings trajectory or capital structure. Overall, the growth and income profile reflects a company with strong top-line expansion driven by revenue growth of 12.5%, but faces challenges in aligning dividend payouts with current net income levels and lacks reported earnings growth metrics to confirm long-term profitability acceleration.